Discussion of Patient Outcomes with a CELMoD
Led By: Eryn DeMaertelaere, RN
In this session, we will cover a number of discussion topics including:
•Underlying factors impacting treatment options for patients with RRMM
•Understanding the CELMoD mechanism: How ZENBEXUS differs from traditional IMiDs
•Clinical efficacy and safety data supporting ZENBEXUS in RRMM
•Identifying the right patient: Optimizing patient selection for ZENBEXUS therapy
•Real-world considerations: Dosing, monitoring, and managing patients on ZENBEXUS